Bärtsch, M., Hillengaß, J., Blocka, J., Schönland, S., Hegenbart, U., Goldschmidt, H., & Raab, M. (2018). Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice. Hematological oncology, 36(1), . https://doi.org/10.1002/hon.2462
Chicago-Zitierstil (17. Ausg.)Bärtsch, Marc-Andrea, Jens Hillengaß, Joanna Blocka, Stefan Schönland, Ute Hegenbart, Hartmut Goldschmidt, und Marc-Steffen Raab. "Efficacy and Tolerability of the Histone Deacetylase Inhibitor Panobinostat in Clinical Practice." Hematological Oncology 36, no. 1 (2018). https://doi.org/10.1002/hon.2462.
MLA-Zitierstil (9. Ausg.)Bärtsch, Marc-Andrea, et al. "Efficacy and Tolerability of the Histone Deacetylase Inhibitor Panobinostat in Clinical Practice." Hematological Oncology, vol. 36, no. 1, 2018, https://doi.org/10.1002/hon.2462.